HITI
High Tide, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · CA
$2.58
−2.64%Next report
Analyst consensus
- Next report date
- Feb 4, 2027
- EPS estimate
- $0.01
- Revenue estimate
- $144.9M
Latest reported
- Last report date
- Sep 15, 2026
- EPS actual
- $0.09
- EPS estimate
- $0.01
- Revenue actual
- $141.7M
- Revenue estimate
- $138.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +428.8%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 15, 2026 | $0.01 | $0.09 | Beat 755.50% | $141.7M |
| Jun 16, 2026 | -$0.02 | $0.01 | Beat 150.00% | $131.9M |
| Mar 18, 2026 | -$0.00 | $0.01 | Beat 508.16% | $130.8M |
| Sep 15, 2025 | -$0.00 | $0.01 | Beat 301.61% | $108.0M |
| Jun 16, 2025 | -$0.02 | -$0.03 | Miss -50.00% | $99.8M |
| Mar 17, 2025 | -$0.01 | -$0.02 | Miss -100.00% | $96.6M |
| Sep 16, 2024 | $0.00 | $0.01 | Beat 139.81% | $94.9M |
| Jun 13, 2024 | -$0.00 | -$0.00 | Miss -76.92% | $90.9M |
| Mar 15, 2024 | -$0.00 | -$0.00 | Miss -100.00% | $95.3M |
| Sep 14, 2023 | -$0.04 | -$0.03 | Beat 25.00% | $93.1M |
| Jun 14, 2023 | -$0.05 | -$0.01 | Beat 80.00% | $86.9M |
| Mar 17, 2023 | -$0.07 | -$0.05 | Beat 28.57% | $88.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 4, 2027